Post by Dosentrx

We’re heading to Asembia's AXS26 April 26-30, 2026!🚀   A different approach to therapy performance.     Dosentrx is defining the category of Therapy Performance Management. The ReX device and Therapy Intelligence Platform enable therapy to be continuously optimized beyond the point of dispensing.   By connecting confirmed dosing behavior with patient context and early clinical signals, we eliminate the blind spots between prescription and outcome, enabling timely intervention and driving measurable improvements in adherence, duration of therapy, and discontinuation risk, while maximizing overall therapy performance and value. Mark Summers, Andrew Gregoire, and Kyler Anderson, PharmD, will be on-site and looking forward to connecting! 🤝   #SpecialtyPharmacy #Pharma #TherapyPerformance #RealWorldData #PatientInsights #Asembia26